Real World Evidence 

   With aging populations and price models no longer fitting the standard. RWE is here to change the way that we price our drugs and deliver new efficacious cures in a sustainable manner to patients. 



RWE, Wednesday 4 December 2019


Registration and Refreshments


Keynote [Reserved for Roche CEO]


Title Sponsor

Frank Lee

Getting your data and applications ready for precision medicine

  • Learn about key capabilities of the underlying reference architecture for high performance data and AI (HPDA) to manage the ocean of data and optimize your AI and big data pipelines for analysis.
  • Understand how to improve data quality through advanced metadata management using content-based and policy-driven data classification & tagging.
  • Discover how to support hybrid multicloud workload orchestration with end-to-end automation of workflows, leveraging containers and cloud using a self-service 'App Hub'.
  • Hear about use cases from the world's fastest genomics pipeline to the largest variant database and explore how your organization can improve speed, scalability, collaboration and ease of use and gain significant cost efficiencies
Georges Heiter

New Frontiers in Data Science – the role of automation in accelerating scientific discovery


Speed Networking


Morning refreshments

round tables


(click to see full list)
Accelerating operations and analytics with High Speed Data sharing across platforms and the world
Laurent Martin

Laurent Martin, Aspera Pre-Sales Engineer - EMEA, IBM Global Markets

Data collection & algorithmic training for biomedical tasks: utilisation and strategies
Anastasia Georgievskaya

Anastasia Georgievskaya, General Manager, Haut.AI

Data Lakes, Getting data ready for analytics, and Personalized Health Data
Christian Blumenroehr

Christian Blumenroehr, Principal Scientist, F. Hoffmann-La Roche

Data Privacy and Democratisation
Matthew Rooney

Matthew Rooney, Chief Clinical Information Officer, Heart of England NHS Foundation Trust

Dell EMC
Design thinking: Driving forwards innovation in pharmaceuticals
Hermann Tribukait

Hermann Tribukait, Founder & CEO, ChemOS Inc.

Diagnosis based on genetic information and public ontologies and databases, improving the diagnosis process of rare disease patients with Foundation29
Pablo Botas

Pablo Botas, Head of Science, Foundation 29

Digital transformation across pharma
Jessica Federer

Jessica Federer, Ex Chief Digital Officer, Bayer

How big data is effecting precision oncology
Andrej Benjak

Andrej Benjak, Bioinformatician, University of Bern

IMI - EDHEN + BD4BO- The pro’s and con’s of the different IMI projects approaches. IT and high tech aspects. Gaining insights into the technical approaches to working with Real World Data at scale. Central vs. Federated; Working to promote FAIR principles
Matthew Wiener

Matthew Wiener, Director, Informatics And Predictive Sciences, Celgene

Investment in AI and Healthcare in China
Vibhor Gupta

Vibhor Gupta, Director and Founder, Pangaea Data

Is bad User Experience (UX) hindering drug discovery? What are the challenges and opportunities for UX in life science software and digital transformation?
Ronald Johnston

Ronald Johnston, Director Of Product And E-Commerce, Merck Digital

Lessons learned in running an AI-enabled operation for precision medicine – privacy, policy, and technical challenges and how we overcame them
Florina Ciorba

Florina Ciorba, Professor Hpc, University Basel

NTT Data
Partnerships across Pharma and Tech – Deals, IP and Timelines
Miron Tokarski

Miron Tokarski, CEO, Genomtec

Phage Display AI and Genomics – Using next generation AI and phage display to generate new immunological targets
Christian Bender

Christian Bender, Data Scientist, Bayer

Reproducibility in Bioinformatics and Big Data Analytics: Myth or Reality?
Raffaele Calogero

Raffaele Calogero, Professor, University of Torino

Roche - All4IBD: a Digital Medicine Toolkit to transform care in Inflammatory Bowel Disease (IBD)
Sumanjit Sethi

Sumanjit Sethi, Digital Health Leader, Immunology, Infectious Diseases and Ophthalmology, F. Hoffmann-La Roche Ltd

Roche - Analytical challenges with multimodal patient data: deriving drug development insights from clinico-molecular data
Gunther Jansen

Gunther Jansen, Group Director, PHC Data Science Analytics, Roche

There is no AI without IA: Building a solid Information Architecture for your AI and high performance Precision Medicine
Frank Lee

Frank Lee, PhD, Global Healthcare and Life Sciences Industry Leader, IBM Systems

Title TBC
Visualisation of good quality data and the pursuit of metrics to drive efficiencies in clinical trials
Paolo Piraino

Paolo Piraino, Head Of Genomics And Biomarker Statistics, Bayer

Western Digital

Networking Lunch

Jeff Barrett

Engaging the Global Health Ecosystem to invest in RWD/RWE to facilitate Translational Medicine and Drug Development Decision Making

Francis Kendall

Real World Analytics – Extracting meaningful value from Real World Data


Afternoon Refreshments


Sensyne Health

Matthew Wiener

Federated & Harmonised Real World Research in the EU 2020+: A Convergence of Intent,Collaboration & Technology?


Afternoon Refreshments

Jacqueline Law

Multi-modal RWD: opportunities and challenges


Drinks Reception

last published: 22/Oct/19 09:35

Contact us

To sponsor or exhibit contact:
Alistair Wilmot
+44 (0)207 092 1174

To speak:
Chris Shanks
+44 (0)207 092 1151